RxDoctor Payments Data

Richard Smith, MD

Family Medicine · Biloxi, MSNPI 1760422885

Payments from drug & device makers

$6,936in general payments, 2019–2025

Across 472 payments — averaging $14.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Pfizer$768
  • AstraZeneca$658
  • Novo Nordisk$470
  • Astellas Pharma US Inc$451
  • Lilly USA, LLC$393
  • plus $3K from 42 others

What the payments were for

  • Consulting fees$250%
  • Food & beverage$6,77198%
  • Education$1402%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,936 in reported general payments places this provider in the 90th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$226,303
Medicare patients
386
Services billed
4,012

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide71$68,263
MounjaroTirzepatide49$55,345
JardianceEmpagliflozin26$39,017
EliquisApixaban36$31,894
TrulicityDulaglutide27$27,014
RybelsusSemaglutide11$18,337
JanuviaSitagliptin Phosphate11$17,203
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$16,334
Tresiba Flextouch U-200Insulin Degludec11$14,036
Lantus SolostarInsulin Glargine,hum.Rec.Anlog55$12,417
MyrbetriqMirabegron16$9,113
Celecoxib191$6,883
Valsartan221$5,888
SymbicortBudesonide/Formoterol Fumarate19$5,739
Asa-Butalb-Caffeine-CodeineCodeine/Butalbital/Asa/Caffein12$4,545

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$470$86,60082 claims
Lilly USA, LLCMounjaro, Trulicity$393$82,35976 claims
Boehringer IngelheimJardiance$153$39,01726 claims
PfizerEliquis$768$31,89436 claims
AstraZenecaBreztri Aerosphere, Symbicort$658$22,07334 claims
MerckJanuvia$45$17,20311 claims
Astellas Pharma US IncMyrbetriq$451$9,11316 claims
AbbVieSynthroid$1,183$2,07525 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Biloxi

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →